Press Releases

2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

2000 Press Releases

Listed below are all of the QLT press releases available for the year you have selected.

December 15	CPMP Recommends Approval in Europe for Visudyne ™ Therapy in the Treatment of Pathologic Myopia	PDF version
December 14	QLT Issues Financial Update On Sales Outlook For Q4 2000	PDF version
December 12	Business Week Selects Visudyne ™ Therapy as One of the 'Best Products of 2000'	PDF version
November 10	Health Care Financing Administration Issues National Coverage Policy for Visudyne ™ Therapy	PDF version
November 9	Drug That Treats Leading Cause of Blindness Wins Popular Science Award	PDF version
October 31	QLT Announces Positive Skin Cancer Results	PDF version
October 17	QLT Announces Third Quarter Financial Results	PDF version
October 11	QLT Announces Visudyne ™ Sales for Third Quarter	PDF version
October 3	Visudyne ™ Supplemental Filing Submitted to European Union Health Authorities by QLT and CIBA Vision	PDF version
September 29	QLT CEO Named Entrepreneur Of The Year, Pacific Region	PDF version
September 6	QLT Announces Senior Management Changes	PDF version
August 29	Visudyne ™ Supplemental Filing Granted Priority Review by FDA	PDF version
August 14	QLT and CIBA Vision Seek to Expand the Indication for Visudyne ™	PDF version
August 1	QLT Announces Financial Results for Second Quarter and First Half of 2000	PDF version
July 28	EU Commission Approves Visudyne ™ for the Treatment of Wet AMD in the European Union	PDF version
July 11	QLT Appoints Vice President, Project Management	PDF version
June 30	QLT Files Counterclaim On Intellectual Property Suit	PDF version
June 9	QLT Announces Completion Of Sale Of PHOTOFRIN® Rights To Axcan	PDF version
June 1	Health Canada Approves Breakthrough Therapy for Devastating Eye Disease	PDF version
May 8	Health Canada Grants Special Access Program For Visudyne ™ Therapy	PDF version
May 5	QLT Announces First Quarter Results	PDF version
May 5	QLT Annual General Meeting Held in Vancouver	PDF version
May 3	Visudyne ™ Data Highlighted At The Association For Research In Vision And Opthalmology Annual Conference	PDF version
May 1	QLT to Sell PHOTOFRIN® Rights to Axcan	PDF version
April 27	QLT Announces Intellectual Property Suit	PDF version
April 17	CIBA Vision and QLT to Expand Strategic Alliance	PDF version
April 13	CPMP Recommends Approval in Europe for Visudyne ™ Therapy in the Treatment of Wet AMD	PDF version
April 12	FDA Approves Visudyne ™ Therapy for AMD	PDF version
March 28	QLT and CIBA Vision Announce Positive Visudyne ™ Clinical Results	PDF version
March 15	Treatment-Investigational New Drug Program for Visudyne ™ Therapy for Wet AMD to Expand in North America	PDF version
March 10	QLT Announces Senior Executive Appointments	PDF version
March 1	QLT Announces Fourth Quarter and 1999 Year-end Results	PDF version
February 11	FDA Takes Positive Action as Visudyne™ Review Nears Completion	PDF version
January 11	Sanofi-Synthelabo Inc. to Convert QLT Preference Shares	PDF version

Visudyne® is a registered trademark of Novartis AG

Vancouver Web Design by Graphically Speaking